David R Gandara

David R Gandara

UNVERIFIED PROFILE

Are you David R Gandara?   Register this Author

Register author
David R Gandara

David R Gandara

Publications by authors named "David R Gandara"

Are you David R Gandara?   Register this Author

100Publications

3227Reads

5Profile Views

EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade.

Clin Lung Cancer 2019 May 27;20(3):e238-e241. Epub 2018 Dec 27.

Department of Internal Medicine, Division of Hematology/Oncology, UC Davis School of Medicine and UC Davis Comprehensive Cancer Center, Sacramento, CA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304183035
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2018.12.015DOI Listing
May 2019

Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:531-542. Epub 2019 May 17.

4 City of Hope Comprehensive Cancer Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_237863DOI Listing
January 2019

CT perfusion imaging of lung cancer: benefit of motion correction for blood flow estimates.

Eur Radiol 2018 Dec 4;28(12):5069-5075. Epub 2018 Jun 4.

Department of Radiology, University of California Davis Medical Center, 4860 Y Street, Suite 3100, Sacramento, CA, 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-018-5492-1DOI Listing
December 2018

In Search of an Oncogene Driver for Squamous Lung Cancer.

JAMA Oncol 2018 Sep;4(9):1197-1198

University of California Davis Comprehensive Cancer Center, Sacramento.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.0774DOI Listing
September 2018

American Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions.

J Glob Oncol 2018 09 11;4:1-8. Epub 2017 Aug 11.

Gabriel N. Hortobagyi, The University of Texas MD Anderson Cancer Center, Houston, TX; Doug Pyle, American Society of Clinical Oncology, Alexandria, VA; Eduardo L. Cazap, Sociedad Latinoamericana y del Caribe de Oncología Médica, Buenos Aires, Argentina; Nagi S. El Saghir, American University of Beirut Medical Center, Beirut, Lebanon; Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA; Gary H. Lyman, Fred Hutchinson Cancer Research Center, Seattle, WA; Lowell E. Schnipper, Beth Israel Deaconess Medical Center, Boston, MA; Clement Adebayo Adebamowo, Institute of Human Virology, Baltimore, MD; David R. Gandara, University of California Davis Comprehensive Cancer Center, Sacramento, CA; Julie Vose, University of Nebraska Medical Center, Omaha, NE; Sandra L. Wong, Dartmouth-Hitchcock Medical Center, Lebanon, NH; and Peter Yu, Hartford HealthCare, Hartford, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.17.00060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180769PMC
September 2018

An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach.

Clin Lung Cancer 2018 01 8;19(1):42-50. Epub 2017 Jun 8.

UC Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.05.019DOI Listing
January 2018

Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC.

Clin Lung Cancer 2018 01 6;19(1):35-41. Epub 2017 Jul 6.

Center for Oncological Research, University of Antwerp, Antwerp, Belgium; Phase I - Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital, Antwerp, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.06.010DOI Listing
January 2018

Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry.

Lung Cancer 2017 10 31;112:165-168. Epub 2017 Aug 31.

University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.015DOI Listing
October 2017

Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non-Small-Cell Lung Cancer.

Clin Lung Cancer 2017 May 21;18(3):281-285. Epub 2016 Nov 21.

Division of Hematology-Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Davis, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.11.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837026PMC
May 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.

Clin Lung Cancer 2017 01 27;18(1):5-12. Epub 2016 Jun 27.

Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.06.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361177PMC
January 2017

Integrated Metabolomics and Proteomics Highlight Altered Nicotinamide- and Polyamine Pathways in Lung Adenocarcinoma.

Carcinogenesis 2017 Jan 3. Epub 2017 Jan 3.

Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California, Davis Medical Center, Sacramento, California

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgw205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862279PMC
January 2017

Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung Cancer.

Clin Lung Cancer 2017 01 24;18(1):1-4. Epub 2016 Dec 24.

University of California, Davis, Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304163038
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2016.12.011DOI Listing
January 2017

Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy.

Cancer Treat Res Commun 2017 ;10:21-26

Division of Hematology/Oncology, University of California, Davis Comprehensive Cancer Center, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2016.12.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519297PMC
January 2017

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer.

J Clin Oncol 2016 11;34(31):3717-3718

Jonathan W. Riess, Primo N. Lara Jr, and David R. Gandara, University of California Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477925PMC
November 2016

Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival.

Clin Proteomics 2016 27;13:31. Epub 2016 Oct 27.

Division of Hematology and Oncology, Department of Internal Medicine, University of California, Davis Medical Center, 4501 X Street, Suite 3016, Sacramento, CA 95817 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12014-016-9132-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084393PMC
October 2016

Postprogression Prolongation of Survival in EGFR-Mutated Lung Cancer: Reconciling the ASPIRATION and IMPRESS Trials.

JAMA Oncol 2016 Mar;2(3):300-1

University of Colorado Cancer Center, Aurora.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.4920DOI Listing
March 2016

Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer.

Cancer Epidemiol Biomarkers Prev 2015 Nov 17;24(11):1716-23. Epub 2015 Aug 17.

Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California, Davis Medical Center, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0427DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633344PMC
November 2015

Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer.

J Thorac Oncol 2015 Oct;10(10):1421-9

*Department of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA; †Department of Internal Medicine, University of Maryland, College Park, MD; ‡Department of Oncology, Lombardi Comprehensive Cancer Center of the Georgetown University, Washington, DC; §Department of Biostatistics, University of California, Davis, CA; ‖Division of Medical Oncology, Swedish Cancer Institute, Seattle, WA; ¶Department of Internal Medicine, Swedish Cancer Institute, Seattle, WA; #Department of Internal Medicine, Comprehensive Cancer Center, University of California, Davis, CA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153351
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000508DOI Listing
October 2015

Patient-Derived Xenografts for Investigation of Acquired Resistance in Oncogene-Driven Cancers: Building a Better Mousetrap.

J Clin Oncol 2015 Sep 27;33(26):2839-40. Epub 2015 Jul 27.

University of California, Davis, Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.9692DOI Listing
September 2015

Lung-MAP--framework, overview, and design principles.

Chin Clin Oncol 2015 Sep;4(3):36

Department of Thoracic and Head and Neck Medical Oncology, University of Texas, MD Anderson Cancer Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2015.09.02DOI Listing
September 2015

EGFR tyrosine kinase inhibitors in squamous cell lung cancer.

Lancet Oncol 2015 Aug 5;16(8):872-3. Epub 2015 Jul 5.

University of California Davis, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)00126-6DOI Listing
August 2015

Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy.

J Thorac Oncol 2015 Jul;10(7):974-84

*Ohio State University Medical Center, Columbus, Ohio; †University of California Davis Comprehensive Cancer Center, Sacramento, California; ‡H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida; §Comprehensive Cancer Center, Medical University of Vienna General Hospital, Vienna, Austria; and ‖Instituto de Biomedicina de Sevilla, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000551DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618296PMC
July 2015

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.

J Thorac Oncol 2015 Jul;10(7):1099-106

*Division of Biomedical Statistics and Informatics, Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota; †Department of Radiation Oncology, Mayo Clinic, Scottsdale, Arizona; ‡Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; §Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University, Durham, North Carolina; ‖Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; ¶Department of Oncology, NCIC Clinical Trials Group, Queen' University, Kingston, ON, Canada; #Department of Hematology & Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia; **Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center, Sacramento, California; ††Department of Statistics for the Data Center/Operations Office, Japan Clinical Oncology Group Data Center, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan; ‡‡Department of Medical Oncology, Japanese Society of Medical Oncology, Tokyo, Japan; §§Department of Medicine, The University of Chicago Medicine and Biologic Sciences Center, Chicago, Illinois; and ‖‖Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153349
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000548DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493926PMC
July 2015

Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma.

Cancer Prev Res (Phila) 2015 May 5;8(5):410-8. Epub 2015 Feb 5.

Division of Hematology and Oncology, Department of Internal Medicine, School of Medicine, University of California, Davis Medical Center, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618700PMC
May 2015

Reply to "diminishing role of platinum-sensitivity status in patients with small cell lung cancer".

J Thorac Oncol 2015 May;10(5):e36

University of California Davis Comprehensive Cancer Center, Sacramento, CA SWOG Statistical Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000515DOI Listing
May 2015

Squamous cell lung cancer: from tumor genomics to cancer therapeutics.

Clin Cancer Res 2015 May;21(10):2236-43

Department of Medicine (Medical Oncology) and Pathology, University of Colorado Denver, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-3039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862209PMC
May 2015

Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines.

J Cancer Res Clin Oncol 2015 Apr 17;141(4):615-26. Epub 2014 Oct 17.

Comprehensive Cancer Center, University of California, Davis, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-014-1855-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562434PMC
April 2015

Targeting of MEK in lung cancer therapeutics.

Lancet Respir Med 2015 Apr 20;3(4):319-27. Epub 2015 Mar 20.

Department of Thoracic Oncology, LungenClinic Grosshansdorf; member of the Airway research center north (ARCN) as part of the German Centre for Lung Research (DZL), Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(15)00026-0DOI Listing
April 2015

SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM).

J Thorac Oncol 2015 Feb;10(2):387-91

*Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA; †SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA; ‡Department of Medicine, Arizona Cancer Center, University of Arizona Tucson School of Medicine, Tucson, AZ; §Department of Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA; ║Fox Chase Cancer Center, Philadelphia, PA; ¶Department of Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and #Department of Medicine, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304604PMC
February 2015

Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials.

J Thorac Oncol 2015 Jan;10(1):110-5

*University of California Davis Comprehensive Cancer Center, Sacramento, California; †SWOG Statistical Center and the Fred Hutchinson Cancer Research Center, Seattle, Washington; ‡Humboldt Medical Specialists, Eureka, California; and §Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000385DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320001PMC
January 2015

Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.

Lung Cancer 2014 Aug 6;85(2):264-9. Epub 2014 May 6.

Division of Hematology Oncology, and University of California Davis Comprehensive Cancer Center, UC Davis School of Medicine Sacramento, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.04.007DOI Listing
August 2014

Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer.

J Clin Oncol 2014 Aug 7;32(23):2463-70. Epub 2014 Jul 7.

Jeffrey W. Allen, University of Tennessee Health Science Center, Memphis, TN; James Moon, Mary Redman, Southwest Oncology Group Statistical Center, Seattle, WA; Shirish M. Gadgeel, Karmanos Cancer Institute, Wayne State University, Detroit, MI; Karen Kelly, Phillip C. Mack, David R. Gandara, University of California Davis Cancer Center, Sacramento, CA; Hanna M. Saba, Central Illinois CCOP/Cancer Care Specialists of Central Illinois, Effingham, IL; Mohamed K. Mohamed, Moses Cone Health System, Greensboro, NC; and Mohammad Jahanzeb, University of Miami, Miami, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.4109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121504PMC
August 2014

Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer.

J Thorac Cardiovasc Surg 2014 Jul 19;148(1):36-40. Epub 2014 Mar 19.

Section of General Thoracic Surgery, University of California, Davis Medical Center, Sacramento, Calif.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2014.03.014DOI Listing
July 2014

Large-scale screening and molecular characterization of EML4-ALK fusion variants in archival non-small-cell lung cancer tumor specimens using quantitative reverse transcription polymerase chain reaction assays.

J Thorac Oncol 2014 Jan;9(1):18-25

*University of California Davis Comprehensive Cancer Center, †Department of Internal Medicine, Division of Hematology & Oncology, University of California, Davis, School of Medicine, Sacramento, California; ‡Department of General-, Visceral- and Tumor Surgery, University of Cologne, Cologne, Germany; §Response Genetics, Inc., Los Angeles, California; ‖Department of Public Health Sciences, University of California, Davis, Davis, California; ¶Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California; and #formerly Response Genetics, Inc., Los Angeles, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000030DOI Listing
January 2014

Phase II trial of carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab in advanced nonsquamous non-small-cell lung cancer: SWOG S0536.

J Thorac Oncol 2013 Dec;8(12):1519-28

*Levine Cancer Institute, Charlotte, North Carolina; †SWOG Statistical Center, Seattle, Washington; ‡Yale Cancer Center, New Haven, Connecticut; §Cancer Center of Kansas and Wichita CCOP, Wichita, Kansas; ‖Central Illinois CCOP and Cancer Care Specialists, Decatur, Illinois; ¶University of Colorado Cancer Center, Aurora, Colorado; #University of California Davis Cancer Center, Sacramento, California; and **MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072123PMC
December 2013

A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2013 Jul 28;72(1):85-91. Epub 2013 May 28.

USC/Norris Comprehensive Cancer Center, Oncology, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2171-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779138PMC
July 2013

FASTACT-2: but don't act too fast.

Lancet Oncol 2013 Jul 17;14(8):684-5. Epub 2013 Jun 17.

University of Colorado Cancer Center, 12801 E 17th Avenue, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70281-XDOI Listing
July 2013

Epidermal growth factor receptor inhibition in lung cancer: status 2012.

J Thorac Oncol 2013 Mar;8(3):373-84

Department of Medicine, Division of Medical Oncology and Department of Pathology, University of Colorado Cancer Center, 12801 E. 17th Avenue, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31827ed0ffDOI Listing
March 2013

Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies.

J Clin Oncol 2013 Mar 11;31(8):1039-49. Epub 2013 Feb 11.

University of California Davis Comprehensive Cancer Center, Division of Hematology and Oncology, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2012.45.3753
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.45.3753DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589700PMC
March 2013

Non-small-cell lung cancer: then and now.

J Clin Oncol 2013 Mar 11;31(8):981-3. Epub 2013 Feb 11.

Division of Hematology-Oncology, University of Texas Southwestern, Dallas, TX 75390-8852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.5772DOI Listing
March 2013

Efficacy and toxicity differences in lung cancer populations in the era of clinical trials globalization: the 'common arm' approach.

Expert Rev Anticancer Ther 2012 Dec;12(12):1591-6

Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA 95817, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.12.135DOI Listing
December 2012